![](/img/cover-not-exists.png)
The APPROACH Study: A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study of Volanesorsen Administered Subcutaneously to Patients with FCS
Gaudet, Daniel, Digenio, Andres, Alexander, Veronica J., Arca, Marcello, Jones, Alan F., Stroes, Erik, Bergeron, Jean, Civeira, Fernando, Hemphill, Linda C., Blom, Dirk J., Flaim, Joann, Hughes, SteveVolume:
32
Language:
english
Journal:
Atherosclerosis Supplements
DOI:
10.1016/j.atherosclerosissup.2018.04.042
Date:
June, 2018
File:
PDF, 182 KB
english, 2018